Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 079111
Company: AUROBINDO PHARMA

Products on ANDA 079111

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RIBAVIRIN	RIBAVIRIN	200MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 079111

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/17/2009	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
04/19/2023	SUPPL-11	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
01/06/2016	SUPPL-7	Labeling-Package Insert		Label is not available on this site.
01/06/2016	SUPPL-6	Labeling-Package Insert		Label is not available on this site.
01/06/2016	SUPPL-4	Labeling-Package Insert		Label is not available on this site.
03/16/2011	SUPPL-1	REMS-Proposal, Labeling-Package Insert, Labeling-Container/Carton Labels		Label is not available on this site.

Therapeutic Equivalents for ANDA 079111

RIBAVIRIN

TABLET;ORAL; 200MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
RIBAVIRIN	RIBAVIRIN	200MG	TABLET;ORAL	Prescription	No	AB	079111	AUROBINDO PHARMA
RIBAVIRIN	RIBAVIRIN	200MG	TABLET;ORAL	Prescription	No	AB	077743	SANDOZ
RIBAVIRIN	RIBAVIRIN	200MG	TABLET;ORAL	Prescription	No	AB	077094	ZYDUS PHARMS USA